TMEM55A-mediated PI5P signaling regulates α-cell actin depolymerization and glucagon secretion.

Area of Science:

• Endocrinology
• Cell Biology
• Molecular Biology

Background:

• Diabetes is linked to pancreatic α-cell dysfunction, impacting glucagon secretion.
• Phospholipid signaling is crucial for insulin secretion but its role in glucagon secretion is poorly understood.

Purpose of the Study:

• To investigate the role of TMEM55A, a lipid phosphatase, in regulating α-cell function and glucagon secretion.
• To elucidate the molecular mechanisms underlying TMEM55A's effects on α-cells.

Main Methods:

• Utilized human and mouse α-cells for experiments.
• Performed TMEM55A knockdown and PI5P reintroduction.
• Assessed exocytosis, Ca2+ channel activity, and F-actin remodeling.

Main Results:

• TMEM55A knockdown reduced α-cell exocytosis at low glucose, which was rescued by PI5P reintroduction.
• TMEM55A's effect on exocytosis was independent of Ca2+ channel activity.
• TMEM55A regulates cortical F-actin remodeling, influenced by its lipid phosphatase activity and oxidative stress.

Conclusions:

• TMEM55A is a key regulator of α-cell exocytosis and glucagon secretion.
• The study reveals a novel pathway involving PI5P levels and F-actin dynamics in α-cell function.
• Findings provide new molecular targets for understanding and potentially treating diabetes-related α-cell dysfunction.